Autonomix jumps after its treatment reduces pain during trial
28/10/2024 13:50
** Medical device maker Autonomix Medical's AMIX.O shares more
than double to $21.07, highest since July
** Company says its radiofrequency ablation procedure reduced
pain in patients with pancreatic cancer
** Says all patients who responded to the procedure went to
zero opioid use at 4-6 weeks post procedure
** Radiofrequency ablation is a minimally invasive procedure
that uses radio waves to destroy abnormal cells or tissue and
treat pain
** As of last close, stock down 92.4% since its IPO in
January
(Reporting by Christy Santhosh)
((mailto:Christy.Santhosh@thomsonreuters.com))